nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—germ cell cancer—brain cancer	0.245	1	CtDrD
Ifosfamide—Alkylating Activity—Lomustine—brain cancer	0.154	0.29	CiPCiCtD
Ifosfamide—Alkylating Activity—Procarbazine—brain cancer	0.154	0.29	CiPCiCtD
Ifosfamide—CYP2C9—brain cancer	0.125	1	CbGaD
Ifosfamide—Alkylating Activity—Temozolomide—brain cancer	0.116	0.22	CiPCiCtD
Ifosfamide—Alkylating Activity—Carmustine—brain cancer	0.106	0.201	CiPCiCtD
Ifosfamide—CYP3A4—Temozolomide—brain cancer	0.00936	0.252	CbGbCtD
Ifosfamide—PTGS1—Etoposide—brain cancer	0.00822	0.221	CbGbCtD
Ifosfamide—CYP3A4—Lomustine—brain cancer	0.00796	0.214	CbGbCtD
Ifosfamide—CYP3A5—Etoposide—brain cancer	0.00493	0.133	CbGbCtD
Ifosfamide—CYP2C8—Etoposide—brain cancer	0.00474	0.128	CbGbCtD
Ifosfamide—CYP3A4—Etoposide—brain cancer	0.00192	0.0518	CbGbCtD
Ifosfamide—Cyclophosphamide—CYP2C9—brain cancer	0.00087	1	CrCbGaD
Ifosfamide—CYP2C18—Xenobiotics—CYP2C9—brain cancer	0.000416	0.0388	CbGpPWpGaD
Ifosfamide—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.000409	0.0381	CbGpPWpGaD
Ifosfamide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.000401	0.0374	CbGpPWpGaD
Ifosfamide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000361	0.0336	CbGpPWpGaD
Ifosfamide—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.000338	0.0315	CbGpPWpGaD
Ifosfamide—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00033	0.0308	CbGpPWpGaD
Ifosfamide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000328	0.0306	CbGpPWpGaD
Ifosfamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000322	0.03	CbGpPWpGaD
Ifosfamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000293	0.0273	CbGpPWpGaD
Ifosfamide—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00028	0.026	CbGpPWpGaD
Ifosfamide—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000277	0.0258	CbGpPWpGaD
Ifosfamide—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000254	0.0236	CbGpPWpGaD
Ifosfamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00025	0.0232	CbGpPWpGaD
Ifosfamide—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000244	0.0227	CbGpPWpGaD
Ifosfamide—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000234	0.0218	CbGpPWpGaD
Ifosfamide—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000205	0.0191	CbGpPWpGaD
Ifosfamide—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.0002	0.0186	CbGpPWpGaD
Ifosfamide—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000192	0.0179	CbGpPWpGaD
Ifosfamide—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000174	0.0162	CbGpPWpGaD
Ifosfamide—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000173	0.0161	CbGpPWpGaD
Ifosfamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000173	0.0161	CbGpPWpGaD
Ifosfamide—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000171	0.0159	CbGpPWpGaD
Ifosfamide—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000167	0.0155	CbGpPWpGaD
Ifosfamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000155	0.0144	CbGpPWpGaD
Ifosfamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000149	0.0139	CbGpPWpGaD
Ifosfamide—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000141	0.0131	CbGpPWpGaD
Ifosfamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00014	0.0131	CbGpPWpGaD
Ifosfamide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000137	0.0128	CbGpPWpGaD
Ifosfamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000134	0.0125	CbGpPWpGaD
Ifosfamide—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000129	0.012	CbGpPWpGaD
Ifosfamide—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	0.000128	0.0119	CbGpPWpGaD
Ifosfamide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000115	0.0107	CbGpPWpGaD
Ifosfamide—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000113	0.0106	CbGpPWpGaD
Ifosfamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000106	0.00989	CbGpPWpGaD
Ifosfamide—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000105	0.00981	CbGpPWpGaD
Ifosfamide—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000104	0.00968	CbGpPWpGaD
Ifosfamide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.32e-05	0.00868	CbGpPWpGaD
Ifosfamide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	9.3e-05	0.00866	CbGpPWpGaD
Ifosfamide—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.03e-05	0.00841	CbGpPWpGaD
Ifosfamide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	8.95e-05	0.00833	CbGpPWpGaD
Ifosfamide—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.54e-05	0.00795	CbGpPWpGaD
Ifosfamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.5e-05	0.00792	CbGpPWpGaD
Ifosfamide—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.39e-05	0.00781	CbGpPWpGaD
Ifosfamide—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	8.33e-05	0.00775	CbGpPWpGaD
Ifosfamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.31e-05	0.00774	CbGpPWpGaD
Ifosfamide—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.2e-05	0.00764	CbGpPWpGaD
Ifosfamide—CYP2C18—Biological oxidations—CYP2C9—brain cancer	7.45e-05	0.00693	CbGpPWpGaD
Ifosfamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	7.43e-05	0.00692	CbGpPWpGaD
Ifosfamide—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	7.34e-05	0.00684	CbGpPWpGaD
Ifosfamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.2e-05	0.0067	CbGpPWpGaD
Ifosfamide—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.1e-05	0.00661	CbGpPWpGaD
Ifosfamide—CYP3A5—Irinotecan Pathway—APC—brain cancer	7.06e-05	0.00657	CbGpPWpGaD
Ifosfamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.89e-05	0.00642	CbGpPWpGaD
Ifosfamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.74e-05	0.00627	CbGpPWpGaD
Ifosfamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	6.42e-05	0.00598	CbGpPWpGaD
Ifosfamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	6.39e-05	0.00595	CbGpPWpGaD
Ifosfamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	6.34e-05	0.0059	CbGpPWpGaD
Ifosfamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	6.08e-05	0.00567	CbGpPWpGaD
Ifosfamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.83e-05	0.00543	CbGpPWpGaD
Ifosfamide—Hyperhidrosis—Procarbazine—brain cancer	5.38e-05	0.00105	CcSEcCtD
Ifosfamide—Renal failure—Carmustine—brain cancer	5.37e-05	0.00105	CcSEcCtD
Ifosfamide—Alopecia—Hydroxyurea—brain cancer	5.36e-05	0.00104	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Carmustine—brain cancer	5.35e-05	0.00104	CcSEcCtD
Ifosfamide—Hyperglycaemia—Temozolomide—brain cancer	5.34e-05	0.00104	CcSEcCtD
Ifosfamide—Stomatitis—Carmustine—brain cancer	5.32e-05	0.00104	CcSEcCtD
Ifosfamide—Pneumonia—Temozolomide—brain cancer	5.3e-05	0.00103	CcSEcCtD
Ifosfamide—Anorexia—Procarbazine—brain cancer	5.3e-05	0.00103	CcSEcCtD
Ifosfamide—Erythema—Hydroxyurea—brain cancer	5.28e-05	0.00103	CcSEcCtD
Ifosfamide—Infestation NOS—Temozolomide—brain cancer	5.27e-05	0.00103	CcSEcCtD
Ifosfamide—Infestation—Temozolomide—brain cancer	5.27e-05	0.00103	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Temozolomide—brain cancer	5.23e-05	0.00102	CcSEcCtD
Ifosfamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.21e-05	0.00485	CbGpPWpGaD
Ifosfamide—Cardiac arrest—Etoposide—brain cancer	5.21e-05	0.00102	CcSEcCtD
Ifosfamide—Nausea—Lomustine—brain cancer	5.21e-05	0.00102	CcSEcCtD
Ifosfamide—Hypotension—Procarbazine—brain cancer	5.2e-05	0.00101	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Temozolomide—brain cancer	5.17e-05	0.00101	CcSEcCtD
Ifosfamide—Stomatitis—Temozolomide—brain cancer	5.14e-05	0.001	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Procarbazine—brain cancer	5.07e-05	0.000989	CcSEcCtD
Ifosfamide—Paraesthesia—Procarbazine—brain cancer	5e-05	0.000975	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Temozolomide—brain cancer	4.99e-05	0.000973	CcSEcCtD
Ifosfamide—CYP3A7—Biological oxidations—CYP2C9—brain cancer	4.95e-05	0.00461	CbGpPWpGaD
Ifosfamide—Somnolence—Procarbazine—brain cancer	4.95e-05	0.000965	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Etoposide—brain cancer	4.93e-05	0.000962	CcSEcCtD
Ifosfamide—Haemoglobin—Carmustine—brain cancer	4.92e-05	0.000961	CcSEcCtD
Ifosfamide—Haemorrhage—Carmustine—brain cancer	4.9e-05	0.000956	CcSEcCtD
Ifosfamide—Ill-defined disorder—Hydroxyurea—brain cancer	4.9e-05	0.000955	CcSEcCtD
Ifosfamide—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	4.88e-05	0.00455	CbGpPWpGaD
Ifosfamide—Anaemia—Hydroxyurea—brain cancer	4.88e-05	0.000951	CcSEcCtD
Ifosfamide—Hallucination—Carmustine—brain cancer	4.87e-05	0.000951	CcSEcCtD
Ifosfamide—Decreased appetite—Procarbazine—brain cancer	4.84e-05	0.000943	CcSEcCtD
Ifosfamide—Connective tissue disorder—Carmustine—brain cancer	4.81e-05	0.000939	CcSEcCtD
Ifosfamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	4.81e-05	0.00448	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—CYP2C9—brain cancer	4.8e-05	0.00447	CbGpPWpGaD
Ifosfamide—Fatigue—Procarbazine—brain cancer	4.8e-05	0.000936	CcSEcCtD
Ifosfamide—Haemoglobin—Temozolomide—brain cancer	4.76e-05	0.000928	CcSEcCtD
Ifosfamide—Malaise—Hydroxyurea—brain cancer	4.76e-05	0.000928	CcSEcCtD
Ifosfamide—Constipation—Procarbazine—brain cancer	4.76e-05	0.000928	CcSEcCtD
Ifosfamide—Pain—Procarbazine—brain cancer	4.76e-05	0.000928	CcSEcCtD
Ifosfamide—Hepatitis—Temozolomide—brain cancer	4.73e-05	0.000924	CcSEcCtD
Ifosfamide—Haemorrhage—Temozolomide—brain cancer	4.73e-05	0.000924	CcSEcCtD
Ifosfamide—Leukopenia—Hydroxyurea—brain cancer	4.72e-05	0.000921	CcSEcCtD
Ifosfamide—Visual impairment—Carmustine—brain cancer	4.72e-05	0.000921	CcSEcCtD
Ifosfamide—Hallucination—Temozolomide—brain cancer	4.71e-05	0.000919	CcSEcCtD
Ifosfamide—Urinary tract disorder—Temozolomide—brain cancer	4.68e-05	0.000912	CcSEcCtD
Ifosfamide—Bronchospasm—Etoposide—brain cancer	4.66e-05	0.000908	CcSEcCtD
Ifosfamide—Connective tissue disorder—Temozolomide—brain cancer	4.65e-05	0.000908	CcSEcCtD
Ifosfamide—Urethral disorder—Temozolomide—brain cancer	4.64e-05	0.000905	CcSEcCtD
Ifosfamide—Feeling abnormal—Procarbazine—brain cancer	4.58e-05	0.000894	CcSEcCtD
Ifosfamide—Eye disorder—Carmustine—brain cancer	4.58e-05	0.000893	CcSEcCtD
Ifosfamide—Convulsion—Hydroxyurea—brain cancer	4.57e-05	0.000892	CcSEcCtD
Ifosfamide—Visual impairment—Temozolomide—brain cancer	4.56e-05	0.00089	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Procarbazine—brain cancer	4.55e-05	0.000888	CcSEcCtD
Ifosfamide—Flushing—Carmustine—brain cancer	4.55e-05	0.000887	CcSEcCtD
Ifosfamide—CYP2A6—Biological oxidations—CYP2C9—brain cancer	4.54e-05	0.00423	CbGpPWpGaD
Ifosfamide—Pancytopenia—Etoposide—brain cancer	4.5e-05	0.000877	CcSEcCtD
Ifosfamide—Erythema multiforme—Temozolomide—brain cancer	4.48e-05	0.000873	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	4.46e-05	0.00087	CcSEcCtD
Ifosfamide—Discomfort—Hydroxyurea—brain cancer	4.44e-05	0.000866	CcSEcCtD
Ifosfamide—Eye disorder—Temozolomide—brain cancer	4.42e-05	0.000863	CcSEcCtD
Ifosfamide—Urticaria—Procarbazine—brain cancer	4.42e-05	0.000862	CcSEcCtD
Ifosfamide—Tinnitus—Temozolomide—brain cancer	4.41e-05	0.000861	CcSEcCtD
Ifosfamide—Body temperature increased—Procarbazine—brain cancer	4.4e-05	0.000858	CcSEcCtD
Ifosfamide—Abdominal pain—Procarbazine—brain cancer	4.4e-05	0.000858	CcSEcCtD
Ifosfamide—Cardiac disorder—Temozolomide—brain cancer	4.39e-05	0.000857	CcSEcCtD
Ifosfamide—Flushing—Temozolomide—brain cancer	4.39e-05	0.000857	CcSEcCtD
Ifosfamide—Arrhythmia—Carmustine—brain cancer	4.38e-05	0.000854	CcSEcCtD
Ifosfamide—Alopecia—Carmustine—brain cancer	4.33e-05	0.000845	CcSEcCtD
Ifosfamide—Oedema—Hydroxyurea—brain cancer	4.31e-05	0.00084	CcSEcCtD
Ifosfamide—Angiopathy—Temozolomide—brain cancer	4.3e-05	0.000838	CcSEcCtD
Ifosfamide—Mental disorder—Carmustine—brain cancer	4.29e-05	0.000837	CcSEcCtD
Ifosfamide—Infection—Hydroxyurea—brain cancer	4.28e-05	0.000834	CcSEcCtD
Ifosfamide—Immune system disorder—Temozolomide—brain cancer	4.28e-05	0.000834	CcSEcCtD
Ifosfamide—Mediastinal disorder—Temozolomide—brain cancer	4.27e-05	0.000832	CcSEcCtD
Ifosfamide—Malnutrition—Carmustine—brain cancer	4.27e-05	0.000832	CcSEcCtD
Ifosfamide—Erythema—Carmustine—brain cancer	4.27e-05	0.000832	CcSEcCtD
Ifosfamide—Chills—Temozolomide—brain cancer	4.25e-05	0.000829	CcSEcCtD
Ifosfamide—Pneumonia—Etoposide—brain cancer	4.24e-05	0.000828	CcSEcCtD
Ifosfamide—Nervous system disorder—Hydroxyurea—brain cancer	4.22e-05	0.000824	CcSEcCtD
Ifosfamide—Infestation NOS—Etoposide—brain cancer	4.22e-05	0.000823	CcSEcCtD
Ifosfamide—Infestation—Etoposide—brain cancer	4.22e-05	0.000823	CcSEcCtD
Ifosfamide—Thrombocytopenia—Hydroxyurea—brain cancer	4.22e-05	0.000822	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Etoposide—brain cancer	4.18e-05	0.000816	CcSEcCtD
Ifosfamide—Alopecia—Temozolomide—brain cancer	4.18e-05	0.000816	CcSEcCtD
Ifosfamide—Skin disorder—Hydroxyurea—brain cancer	4.18e-05	0.000816	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Etoposide—brain cancer	4.16e-05	0.000812	CcSEcCtD
Ifosfamide—Renal failure—Etoposide—brain cancer	4.15e-05	0.000809	CcSEcCtD
Ifosfamide—Mental disorder—Temozolomide—brain cancer	4.15e-05	0.000809	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Etoposide—brain cancer	4.14e-05	0.000807	CcSEcCtD
Ifosfamide—Myocardial infarction—Etoposide—brain cancer	4.14e-05	0.000807	CcSEcCtD
Ifosfamide—Erythema—Temozolomide—brain cancer	4.12e-05	0.000804	CcSEcCtD
Ifosfamide—Malnutrition—Temozolomide—brain cancer	4.12e-05	0.000804	CcSEcCtD
Ifosfamide—Stomatitis—Etoposide—brain cancer	4.11e-05	0.000803	CcSEcCtD
Ifosfamide—Anorexia—Hydroxyurea—brain cancer	4.1e-05	0.000801	CcSEcCtD
Ifosfamide—Hypersensitivity—Procarbazine—brain cancer	4.1e-05	0.0008	CcSEcCtD
Ifosfamide—Vision blurred—Carmustine—brain cancer	4.02e-05	0.000784	CcSEcCtD
Ifosfamide—Asthenia—Procarbazine—brain cancer	3.99e-05	0.000779	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Etoposide—brain cancer	3.99e-05	0.000779	CcSEcCtD
Ifosfamide—Anaemia—Carmustine—brain cancer	3.94e-05	0.000769	CcSEcCtD
Ifosfamide—Agranulocytosis—Etoposide—brain cancer	3.94e-05	0.000768	CcSEcCtD
Ifosfamide—Pruritus—Procarbazine—brain cancer	3.94e-05	0.000768	CcSEcCtD
Ifosfamide—Agitation—Carmustine—brain cancer	3.92e-05	0.000765	CcSEcCtD
Ifosfamide—Vision blurred—Temozolomide—brain cancer	3.88e-05	0.000758	CcSEcCtD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	3.86e-05	0.0036	CbGpPWpGaD
Ifosfamide—Dyspnoea—Hydroxyurea—brain cancer	3.84e-05	0.000749	CcSEcCtD
Ifosfamide—Somnolence—Hydroxyurea—brain cancer	3.83e-05	0.000747	CcSEcCtD
Ifosfamide—Ill-defined disorder—Temozolomide—brain cancer	3.82e-05	0.000746	CcSEcCtD
Ifosfamide—Leukopenia—Carmustine—brain cancer	3.82e-05	0.000745	CcSEcCtD
Ifosfamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	3.81e-05	0.00355	CbGpPWpGaD
Ifosfamide—Anaemia—Temozolomide—brain cancer	3.81e-05	0.000743	CcSEcCtD
Ifosfamide—Diarrhoea—Procarbazine—brain cancer	3.81e-05	0.000743	CcSEcCtD
Ifosfamide—Agitation—Temozolomide—brain cancer	3.79e-05	0.000739	CcSEcCtD
Ifosfamide—Angioedema—Temozolomide—brain cancer	3.77e-05	0.000735	CcSEcCtD
Ifosfamide—Decreased appetite—Hydroxyurea—brain cancer	3.74e-05	0.00073	CcSEcCtD
Ifosfamide—Urinary tract disorder—Etoposide—brain cancer	3.74e-05	0.00073	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	3.72e-05	0.000725	CcSEcCtD
Ifosfamide—Malaise—Temozolomide—brain cancer	3.72e-05	0.000725	CcSEcCtD
Ifosfamide—Urethral disorder—Etoposide—brain cancer	3.71e-05	0.000724	CcSEcCtD
Ifosfamide—Fatigue—Hydroxyurea—brain cancer	3.71e-05	0.000724	CcSEcCtD
Ifosfamide—Vertigo—Temozolomide—brain cancer	3.7e-05	0.000722	CcSEcCtD
Ifosfamide—Convulsion—Carmustine—brain cancer	3.7e-05	0.000721	CcSEcCtD
Ifosfamide—Leukopenia—Temozolomide—brain cancer	3.69e-05	0.00072	CcSEcCtD
Ifosfamide—Hypertension—Carmustine—brain cancer	3.68e-05	0.000718	CcSEcCtD
Ifosfamide—Pain—Hydroxyurea—brain cancer	3.68e-05	0.000718	CcSEcCtD
Ifosfamide—Constipation—Hydroxyurea—brain cancer	3.68e-05	0.000718	CcSEcCtD
Ifosfamide—Dizziness—Procarbazine—brain cancer	3.68e-05	0.000718	CcSEcCtD
Ifosfamide—CYP2B6—Biological oxidations—CYP2C9—brain cancer	3.66e-05	0.00341	CbGpPWpGaD
Ifosfamide—Palpitations—Temozolomide—brain cancer	3.64e-05	0.000711	CcSEcCtD
Ifosfamide—Myalgia—Carmustine—brain cancer	3.63e-05	0.000708	CcSEcCtD
Ifosfamide—Chest pain—Carmustine—brain cancer	3.63e-05	0.000708	CcSEcCtD
Ifosfamide—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	3.61e-05	0.00336	CbGpPWpGaD
Ifosfamide—Cough—Temozolomide—brain cancer	3.6e-05	0.000702	CcSEcCtD
Ifosfamide—Erythema multiforme—Etoposide—brain cancer	3.58e-05	0.000699	CcSEcCtD
Ifosfamide—CYP3A5—Biological oxidations—CYP2C9—brain cancer	3.58e-05	0.00333	CbGpPWpGaD
Ifosfamide—Convulsion—Temozolomide—brain cancer	3.57e-05	0.000697	CcSEcCtD
Ifosfamide—Hypertension—Temozolomide—brain cancer	3.56e-05	0.000694	CcSEcCtD
Ifosfamide—Feeling abnormal—Hydroxyurea—brain cancer	3.55e-05	0.000692	CcSEcCtD
Ifosfamide—Eye disorder—Etoposide—brain cancer	3.54e-05	0.000691	CcSEcCtD
Ifosfamide—Vomiting—Procarbazine—brain cancer	3.54e-05	0.00069	CcSEcCtD
Ifosfamide—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	3.53e-05	0.00329	CbGpPWpGaD
Ifosfamide—Cardiac disorder—Etoposide—brain cancer	3.52e-05	0.000686	CcSEcCtD
Ifosfamide—Flushing—Etoposide—brain cancer	3.52e-05	0.000686	CcSEcCtD
Ifosfamide—Confusional state—Carmustine—brain cancer	3.51e-05	0.000685	CcSEcCtD
Ifosfamide—Myalgia—Temozolomide—brain cancer	3.51e-05	0.000685	CcSEcCtD
Ifosfamide—Arthralgia—Temozolomide—brain cancer	3.51e-05	0.000685	CcSEcCtD
Ifosfamide—Rash—Procarbazine—brain cancer	3.51e-05	0.000684	CcSEcCtD
Ifosfamide—Dermatitis—Procarbazine—brain cancer	3.5e-05	0.000684	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	3.48e-05	0.00068	CcSEcCtD
Ifosfamide—Oedema—Carmustine—brain cancer	3.48e-05	0.000679	CcSEcCtD
Ifosfamide—Discomfort—Temozolomide—brain cancer	3.47e-05	0.000676	CcSEcCtD
Ifosfamide—Infection—Carmustine—brain cancer	3.46e-05	0.000675	CcSEcCtD
Ifosfamide—Angiopathy—Etoposide—brain cancer	3.44e-05	0.000671	CcSEcCtD
Ifosfamide—Immune system disorder—Etoposide—brain cancer	3.42e-05	0.000668	CcSEcCtD
Ifosfamide—Mediastinal disorder—Etoposide—brain cancer	3.41e-05	0.000666	CcSEcCtD
Ifosfamide—Thrombocytopenia—Carmustine—brain cancer	3.41e-05	0.000665	CcSEcCtD
Ifosfamide—Body temperature increased—Hydroxyurea—brain cancer	3.4e-05	0.000664	CcSEcCtD
Ifosfamide—Chills—Etoposide—brain cancer	3.4e-05	0.000663	CcSEcCtD
Ifosfamide—Confusional state—Temozolomide—brain cancer	3.39e-05	0.000662	CcSEcCtD
Ifosfamide—Anaphylactic shock—Temozolomide—brain cancer	3.36e-05	0.000656	CcSEcCtD
Ifosfamide—Oedema—Temozolomide—brain cancer	3.36e-05	0.000656	CcSEcCtD
Ifosfamide—Alopecia—Etoposide—brain cancer	3.35e-05	0.000653	CcSEcCtD
Ifosfamide—Infection—Temozolomide—brain cancer	3.34e-05	0.000652	CcSEcCtD
Ifosfamide—Anorexia—Carmustine—brain cancer	3.32e-05	0.000647	CcSEcCtD
Ifosfamide—Nausea—Procarbazine—brain cancer	3.3e-05	0.000645	CcSEcCtD
Ifosfamide—Nervous system disorder—Temozolomide—brain cancer	3.3e-05	0.000644	CcSEcCtD
Ifosfamide—Thrombocytopenia—Temozolomide—brain cancer	3.29e-05	0.000642	CcSEcCtD
Ifosfamide—CYP3A4—Irinotecan Pathway—APC—brain cancer	3.28e-05	0.00306	CbGpPWpGaD
Ifosfamide—Skin disorder—Temozolomide—brain cancer	3.27e-05	0.000637	CcSEcCtD
Ifosfamide—Hypotension—Carmustine—brain cancer	3.25e-05	0.000635	CcSEcCtD
Ifosfamide—Hyperhidrosis—Temozolomide—brain cancer	3.25e-05	0.000634	CcSEcCtD
Ifosfamide—Anorexia—Temozolomide—brain cancer	3.21e-05	0.000626	CcSEcCtD
Ifosfamide—Hypersensitivity—Hydroxyurea—brain cancer	3.17e-05	0.000619	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Carmustine—brain cancer	3.17e-05	0.000619	CcSEcCtD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.13e-05	0.00292	CbGpPWpGaD
Ifosfamide—Paraesthesia—Carmustine—brain cancer	3.13e-05	0.00061	CcSEcCtD
Ifosfamide—Dyspnoea—Carmustine—brain cancer	3.1e-05	0.000605	CcSEcCtD
Ifosfamide—CYP2C8—Biological oxidations—CYP2C9—brain cancer	3.1e-05	0.00289	CbGpPWpGaD
Ifosfamide—Somnolence—Carmustine—brain cancer	3.09e-05	0.000604	CcSEcCtD
Ifosfamide—Asthenia—Hydroxyurea—brain cancer	3.09e-05	0.000603	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Temozolomide—brain cancer	3.06e-05	0.000598	CcSEcCtD
Ifosfamide—Ill-defined disorder—Etoposide—brain cancer	3.06e-05	0.000597	CcSEcCtD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	3.06e-05	0.00285	CbGpPWpGaD
Ifosfamide—Anaemia—Etoposide—brain cancer	3.05e-05	0.000595	CcSEcCtD
Ifosfamide—Decreased appetite—Carmustine—brain cancer	3.03e-05	0.00059	CcSEcCtD
Ifosfamide—Paraesthesia—Temozolomide—brain cancer	3.02e-05	0.000589	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Carmustine—brain cancer	3.01e-05	0.000586	CcSEcCtD
Ifosfamide—Dyspnoea—Temozolomide—brain cancer	3e-05	0.000585	CcSEcCtD
Ifosfamide—Somnolence—Temozolomide—brain cancer	2.99e-05	0.000583	CcSEcCtD
Ifosfamide—Pain—Carmustine—brain cancer	2.98e-05	0.000581	CcSEcCtD
Ifosfamide—Constipation—Carmustine—brain cancer	2.98e-05	0.000581	CcSEcCtD
Ifosfamide—Malaise—Etoposide—brain cancer	2.97e-05	0.00058	CcSEcCtD
Ifosfamide—Vertigo—Etoposide—brain cancer	2.96e-05	0.000578	CcSEcCtD
Ifosfamide—Leukopenia—Etoposide—brain cancer	2.95e-05	0.000576	CcSEcCtD
Ifosfamide—Diarrhoea—Hydroxyurea—brain cancer	2.95e-05	0.000575	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	2.94e-05	0.00274	CbGpPWpGaD
Ifosfamide—Decreased appetite—Temozolomide—brain cancer	2.92e-05	0.00057	CcSEcCtD
Ifosfamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	2.91e-05	0.00271	CbGpPWpGaD
Ifosfamide—Gastrointestinal disorder—Temozolomide—brain cancer	2.9e-05	0.000567	CcSEcCtD
Ifosfamide—Fatigue—Temozolomide—brain cancer	2.9e-05	0.000566	CcSEcCtD
Ifosfamide—Cough—Etoposide—brain cancer	2.88e-05	0.000561	CcSEcCtD
Ifosfamide—Pain—Temozolomide—brain cancer	2.88e-05	0.000561	CcSEcCtD
Ifosfamide—Constipation—Temozolomide—brain cancer	2.88e-05	0.000561	CcSEcCtD
Ifosfamide—Feeling abnormal—Carmustine—brain cancer	2.87e-05	0.00056	CcSEcCtD
Ifosfamide—Convulsion—Etoposide—brain cancer	2.86e-05	0.000557	CcSEcCtD
Ifosfamide—Hypertension—Etoposide—brain cancer	2.85e-05	0.000555	CcSEcCtD
Ifosfamide—Dizziness—Hydroxyurea—brain cancer	2.85e-05	0.000555	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Carmustine—brain cancer	2.85e-05	0.000555	CcSEcCtD
Ifosfamide—Chest pain—Etoposide—brain cancer	2.81e-05	0.000548	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	2.79e-05	0.000544	CcSEcCtD
Ifosfamide—Discomfort—Etoposide—brain cancer	2.77e-05	0.000541	CcSEcCtD
Ifosfamide—Feeling abnormal—Temozolomide—brain cancer	2.77e-05	0.000541	CcSEcCtD
Ifosfamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	2.77e-05	0.00258	CbGpPWpGaD
Ifosfamide—Abdominal pain—Carmustine—brain cancer	2.75e-05	0.000537	CcSEcCtD
Ifosfamide—Body temperature increased—Carmustine—brain cancer	2.75e-05	0.000537	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Temozolomide—brain cancer	2.75e-05	0.000537	CcSEcCtD
Ifosfamide—Vomiting—Hydroxyurea—brain cancer	2.74e-05	0.000534	CcSEcCtD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	2.73e-05	0.00254	CbGpPWpGaD
Ifosfamide—Rash—Hydroxyurea—brain cancer	2.71e-05	0.00053	CcSEcCtD
Ifosfamide—Confusional state—Etoposide—brain cancer	2.71e-05	0.000529	CcSEcCtD
Ifosfamide—Dermatitis—Hydroxyurea—brain cancer	2.71e-05	0.000529	CcSEcCtD
Ifosfamide—Anaphylactic shock—Etoposide—brain cancer	2.69e-05	0.000525	CcSEcCtD
Ifosfamide—Infection—Etoposide—brain cancer	2.67e-05	0.000522	CcSEcCtD
Ifosfamide—Urticaria—Temozolomide—brain cancer	2.67e-05	0.000521	CcSEcCtD
Ifosfamide—Abdominal pain—Temozolomide—brain cancer	2.66e-05	0.000519	CcSEcCtD
Ifosfamide—Body temperature increased—Temozolomide—brain cancer	2.66e-05	0.000519	CcSEcCtD
Ifosfamide—Thrombocytopenia—Etoposide—brain cancer	2.64e-05	0.000514	CcSEcCtD
Ifosfamide—Skin disorder—Etoposide—brain cancer	2.61e-05	0.00051	CcSEcCtD
Ifosfamide—Hyperhidrosis—Etoposide—brain cancer	2.6e-05	0.000508	CcSEcCtD
Ifosfamide—Anorexia—Etoposide—brain cancer	2.57e-05	0.000501	CcSEcCtD
Ifosfamide—Hypersensitivity—Carmustine—brain cancer	2.56e-05	0.0005	CcSEcCtD
Ifosfamide—Nausea—Hydroxyurea—brain cancer	2.56e-05	0.000499	CcSEcCtD
Ifosfamide—Hypotension—Etoposide—brain cancer	2.52e-05	0.000491	CcSEcCtD
Ifosfamide—Asthenia—Carmustine—brain cancer	2.5e-05	0.000487	CcSEcCtD
Ifosfamide—Hypersensitivity—Temozolomide—brain cancer	2.48e-05	0.000483	CcSEcCtD
Ifosfamide—Paraesthesia—Etoposide—brain cancer	2.42e-05	0.000472	CcSEcCtD
Ifosfamide—Asthenia—Temozolomide—brain cancer	2.41e-05	0.000471	CcSEcCtD
Ifosfamide—Dyspnoea—Etoposide—brain cancer	2.4e-05	0.000468	CcSEcCtD
Ifosfamide—Somnolence—Etoposide—brain cancer	2.39e-05	0.000467	CcSEcCtD
Ifosfamide—Diarrhoea—Carmustine—brain cancer	2.38e-05	0.000465	CcSEcCtD
Ifosfamide—Pruritus—Temozolomide—brain cancer	2.38e-05	0.000464	CcSEcCtD
Ifosfamide—Decreased appetite—Etoposide—brain cancer	2.34e-05	0.000456	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Etoposide—brain cancer	2.32e-05	0.000453	CcSEcCtD
Ifosfamide—Fatigue—Etoposide—brain cancer	2.32e-05	0.000453	CcSEcCtD
Ifosfamide—Dizziness—Carmustine—brain cancer	2.3e-05	0.000449	CcSEcCtD
Ifosfamide—Pain—Etoposide—brain cancer	2.3e-05	0.000449	CcSEcCtD
Ifosfamide—Constipation—Etoposide—brain cancer	2.3e-05	0.000449	CcSEcCtD
Ifosfamide—Diarrhoea—Temozolomide—brain cancer	2.3e-05	0.000449	CcSEcCtD
Ifosfamide—Dizziness—Temozolomide—brain cancer	2.22e-05	0.000434	CcSEcCtD
Ifosfamide—Feeling abnormal—Etoposide—brain cancer	2.22e-05	0.000433	CcSEcCtD
Ifosfamide—Vomiting—Carmustine—brain cancer	2.21e-05	0.000432	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Etoposide—brain cancer	2.2e-05	0.000429	CcSEcCtD
Ifosfamide—Rash—Carmustine—brain cancer	2.19e-05	0.000428	CcSEcCtD
Ifosfamide—Dermatitis—Carmustine—brain cancer	2.19e-05	0.000428	CcSEcCtD
Ifosfamide—Vomiting—Temozolomide—brain cancer	2.14e-05	0.000417	CcSEcCtD
Ifosfamide—Urticaria—Etoposide—brain cancer	2.14e-05	0.000417	CcSEcCtD
Ifosfamide—Abdominal pain—Etoposide—brain cancer	2.13e-05	0.000415	CcSEcCtD
Ifosfamide—Body temperature increased—Etoposide—brain cancer	2.13e-05	0.000415	CcSEcCtD
Ifosfamide—Rash—Temozolomide—brain cancer	2.12e-05	0.000414	CcSEcCtD
Ifosfamide—Dermatitis—Temozolomide—brain cancer	2.12e-05	0.000413	CcSEcCtD
Ifosfamide—Nausea—Carmustine—brain cancer	2.07e-05	0.000403	CcSEcCtD
Ifosfamide—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	2.04e-05	0.0019	CbGpPWpGaD
Ifosfamide—Nausea—Temozolomide—brain cancer	2e-05	0.00039	CcSEcCtD
Ifosfamide—Hypersensitivity—Etoposide—brain cancer	1.98e-05	0.000387	CcSEcCtD
Ifosfamide—Asthenia—Etoposide—brain cancer	1.93e-05	0.000377	CcSEcCtD
Ifosfamide—Pruritus—Etoposide—brain cancer	1.9e-05	0.000372	CcSEcCtD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.84e-05	0.00172	CbGpPWpGaD
Ifosfamide—Diarrhoea—Etoposide—brain cancer	1.84e-05	0.000359	CcSEcCtD
Ifosfamide—Dizziness—Etoposide—brain cancer	1.78e-05	0.000347	CcSEcCtD
Ifosfamide—Vomiting—Etoposide—brain cancer	1.71e-05	0.000334	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	1.7e-05	0.00158	CbGpPWpGaD
Ifosfamide—Rash—Etoposide—brain cancer	1.7e-05	0.000331	CcSEcCtD
Ifosfamide—Dermatitis—Etoposide—brain cancer	1.7e-05	0.000331	CcSEcCtD
Ifosfamide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	1.66e-05	0.00155	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	1.64e-05	0.00153	CbGpPWpGaD
Ifosfamide—Nausea—Etoposide—brain cancer	1.6e-05	0.000312	CcSEcCtD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.35e-05	0.00125	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP2C9—brain cancer	1.27e-05	0.00119	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.19e-05	0.00111	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—BSG—brain cancer	1.08e-05	0.00101	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.06e-05	0.000989	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—IDH1—brain cancer	9.31e-06	0.000867	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.7e-06	0.00081	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP2C9—brain cancer	8.47e-06	0.000788	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP2C9—brain cancer	8.21e-06	0.000764	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.77e-06	0.000723	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP2C9—brain cancer	7.76e-06	0.000723	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ENO2—brain cancer	7.36e-06	0.000685	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—BSG—brain cancer	7.2e-06	0.00067	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.08e-06	0.00066	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—BSG—brain cancer	6.98e-06	0.00065	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—BSG—brain cancer	6.6e-06	0.000614	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP2C9—brain cancer	6.26e-06	0.000583	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—IDH1—brain cancer	6.19e-06	0.000576	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP2C9—brain cancer	6.12e-06	0.00057	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—IDH1—brain cancer	6e-06	0.000559	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—IDH1—brain cancer	5.67e-06	0.000528	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—BSG—brain cancer	5.32e-06	0.000496	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP2C9—brain cancer	5.3e-06	0.000494	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—BSG—brain cancer	5.2e-06	0.000485	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ENO2—brain cancer	4.89e-06	0.000456	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.89e-06	0.000455	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ENO2—brain cancer	4.74e-06	0.000442	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2C9—brain cancer	4.73e-06	0.000441	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—IDH1—brain cancer	4.58e-06	0.000426	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—BSG—brain cancer	4.51e-06	0.00042	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ENO2—brain cancer	4.48e-06	0.000418	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—IDH1—brain cancer	4.47e-06	0.000417	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—BSG—brain cancer	4.02e-06	0.000375	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—IDH1—brain cancer	3.88e-06	0.000361	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—BSG—brain cancer	3.67e-06	0.000342	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ENO2—brain cancer	3.62e-06	0.000337	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ENO2—brain cancer	3.54e-06	0.000329	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—IDH1—brain cancer	3.46e-06	0.000322	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CG—brain cancer	3.38e-06	0.000314	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.16e-06	0.000294	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—IDH1—brain cancer	3.15e-06	0.000294	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ENO2—brain cancer	3.06e-06	0.000285	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2C9—brain cancer	2.84e-06	0.000265	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.82e-06	0.000262	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ENO2—brain cancer	2.73e-06	0.000255	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.57e-06	0.000239	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ENO2—brain cancer	2.49e-06	0.000232	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BSG—brain cancer	2.42e-06	0.000225	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—brain cancer	2.24e-06	0.000209	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—brain cancer	2.18e-06	0.000203	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—IDH1—brain cancer	2.08e-06	0.000194	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—brain cancer	2.06e-06	0.000192	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—brain cancer	1.66e-06	0.000155	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ENO2—brain cancer	1.64e-06	0.000153	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—brain cancer	1.62e-06	0.000151	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—brain cancer	1.41e-06	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—brain cancer	1.25e-06	0.000117	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—brain cancer	1.14e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—brain cancer	7.54e-07	7.02e-05	CbGpPWpGaD
